COMPARATIVE STUDY ON WOUND HEALING WITH BETADINE, SILVER SULPHADIAZINE, SOFRAMYCIN AND PHENYTOIN AS DRESSING AGENTS IN DIABETIC FOOT ULCERS

Main Article Content

Dr. Bodagala Venkata Radha Krishna Teja
Dr. Budamala Sarada
Dr. M Pradeep
Dr. Padala Adithya
Dr. Aluvala Vamshi Krishna
Dr. Bukke Ramanjineyulu Naik

Keywords

.

Abstract

Background: Diabetic foot ulcer is a major global concern accounting for huge chunk of global healthcare attention and patient suffering. Dressing agents like betadine, silver sulphadiazine, soframycin and phenytoin show promising results with reducing duration of diabetic foot ulcers and its complications. The intention of this particular study is to compare efficacy of each of the four mentioned dressings and compare their rate of granulation and epithelization in diabetic foot ulcers.


Methods: Diabetic patients presented with foot ulcers were divided into 4 groups of 50 in each group.In Group 1 , Betadine is used as Dressing agent. In Group 2, Silver sulphadiazine is used as dressing agent.In Group 3 , Soframycin is used as dressing agent. In Group 4 ,Phenytoin is used as dressing agent.


Study design – A Prospective interventional study in a Tertiary care hospital


Duration of the study – 12 months from institutional scientific committee and institutional ethical committee approval


The wound surface areas are measured using Graph paper – Tracing method. The wound surface areas were measured initially at the beginning of the study and one again at the 21st day.


Results: The reduction in ulcer surface area is expressed as percentage points in comparision to ulcer surface area at the start of the study to the ulcer surface area at the end of 21 days . Group 1 (Betadine) showed a reduction in ulcer surface area at 57.59±14.456% , Group 2 (silver sulphadiazine) showed a reduction in ulcer surface area at 56.74 ± 12.710 % , Group 3 (Soframycin) showed a reduction in ulcer surface area at 54.16 ± 15.512% with  and Group 4(Phenytoin) showed a reduction of ulcer surface area at 61.46 ± 8.938%


Conclusion: The diabetic foot ulcers in Topical phenytoin dressing group contracted more than those in patients with Betadine, Silver sulphadiazine and Soframycin groups (61.46% as compared to 57.59%, 56.74% and 54.16% with statistical significance), which indicates that the Topical Phenytoin dressing therapy is one of the effective modality to aid the reduction of wound surface area in patients suffering from diabetic ulcer. 

Abstract 602 | pdf Downloads 83

References

1. Delshad E, Tavakkoli-kakhki M, Motavasselian M. Successful Repair of Diabetic Foot Ulcer with Honey-Based Treatment A Case Report. Iran Red Crescent Med J. 201619
2. Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018 Feb14(2)88-98.
3. Goyal R, Jialal I. Diabetes Mellitus Type 2. In StatPearls [Internet]. Treasure Island (FL) StatPearls Publishing 2021 [cited 2021 Jun 24]. Available from http//www.ncbi.nlm. nih.gov/books/NBK513253/
4. Armstrong DG, Boulton AJM, Bus SA. Diabetic Foot Ulcers and Their Recurrence. N Engl J Med. 2017 Jun 15376(24)2367-2375.
5. Mutluoglu M, Uzun G, Turhan V, Gorenek L, Ay H, Lipsky BA. How reliable are cultures of specimens from superficial swabs compared with those of deep tissue in patients with diabetic foot ulcers J Diabetes Complications.2012 May- Jun26(3)225-9.
6. Oliver TI, Mutluoglu M. Diabetic Foot Ulcer. In StatPearls [Internet]. Treasure Island (FL) StatPearls Publishing 2021 [cited 2021 Jun 24]. Available from http//www.ncbi. nlm.nih.gov/books/NBK537328/
7. lavi, A. Sibbald, R.G. Mayer, D. Goodman, L. Botros, M. Armstrong, D.G. Woo, K. Boeni, T. Ayello, E.A. Kirsner, R.S. Diabetic foot ulcers Part, I. Pathophysiology and prevention. J. Am. Acad. Dermatol. 2014, 70, 1.e1–1.e18.81
8. Aumiller, W.D. Dollahite, H.A. Pathogenesis and management of diabetic foot ulcers. J. Am. Acad. PAs 2015, 28, 28–34. 10. Noor, S. Zubair, M. Ahmad, J. Diabetic foot ulcer—A review on pathophysiology, classification and microbial etiology. Diabetes Metab. Syndr. Clin. Res. Rev. 2015, 9, 192–199
9. Chantelau, E.A. Nociception at the diabetic foot, an uncharted territory. World J. Diabetes 2015, 6, 391–402
10. Agarwal, S., Bhardwaj, V., Singh, A., Goel, S., Bharat, M., & Krishna, J. A. I. (2015). a Control Clinical Trial of Honey-Impregnated and Povidone Iodine Dressings in the Treatment of Diabetic Foot Ulcers Among Northern Indian Subjects. International Wound Journal, 6(2), 7–10
11. Chitrambalam, T.G.; Christopher, P.J.; Sundaraj, J.; Paladugu, R.; Selvamuthukumaran, S. Comparison of Efficacy of Alginate Filler Dressings with Conventional Saline Dressings for Cavity Wounds in Diabetic Foot Ulcer- A Prospective Cohort Study. J.Clin. Diagn. Res. 2020, 14, PC1–PC4.
12. Singh B, Kapoor S, Gupta AK. Comparing the efficacy of nano crystalline silver dressing versus betadine dressing in management of diabetic foot ulcer. Int Surg J. 2020;7(5):1424. doi:10.18203/2349- 2902.isj20201568
13. Bohannon RW, Pfaller BA. Documentation of wound surface area from tracings of wound perimeters. Clinical report on three techniques. Phys Ther. 1983 Oct;63(10):1622-4. doi: 10.1093/ptj/63.10.1622. PMID: 6622538.
14. Naik BN, Srinivasan M, Reddy MM, Kanungo S, Sarkar S, Kar SS. Diabetes Foot Ulcer Risk - A Public Health Concern in Rural Pondicherry!!. Natl J Community Med 2018;9(10):755-759
15. J.Shaw, C.M.Hughes, K.M.Lagan, M.R.Stevenson, C.R Irwin, P.M.Bell , The effect of topical phenytoin on healing in diabetic foot ulcers : a randomized controlled trial. Wiley Online Library ,11 April 2011, https://doi.org/10.1111/j.1464-5491.2011.03309.x 87
16. Tauro et al., 2013, A Comparative Study of Efficacy of Topical Phenytoin vs Conventional Wound Care in Diabetic Ulcers, International Journal of Molecular Medical Science, Vol.3, No.8 pp.65-71 (doi: 10.5376/ijmms.2013.03.0008)
17. Edmonds ME, Foster AV (2006) Diabetic foot ulcers. BritMed J 332:407–410
18. Inchingolo, F.; Vermesan, D.; Inchingolo, A.D.; Malcangi, G.; Santacroce, L.; Scacco, S.; Benagiano, V.; Girolamo, F.; Cagiano, R.;Caprio, M.; et al. Bedsores Successfully Treated with Topical Phenytoin. Acta Biomed. 2017, 88, 45–48. [CrossRef]
19. Muthukumaraswamy MG, Sivakumar G, Manoharan G. Topical phenytoin in diabetic loot ulcers. Diabetes Care 1991;14:909-11
20. Anstead, G.M.; Hart, L.M.; Sunahara, J.F.; Liter, M.E. Phenytoin in wound healing. Ann. Pharmacother. 1996,30, 768–775. [CrossRef] [PubMed]
21. Talas G., Brown R.A., McGrouther D.A. Role of phenytoin in wound healing—a wound pharmacology perspective. Biochem. Pharmacol. 1999;57:1085–1094. [Abstract] [Google Scholar]
22. P.G. Genever, I.R. Dickson, Influence of vitamin D status on hyaluronan localization in bone, Bone, Volume 18, Issue 5,1996, Pages 429-435,ISSN 8756-3282, https://doi.org/10.1016/8756-3282(96)00046-4
23. Dill, R. E., E. K. Miller, T. Weil, S. Lesley, G. R. Farmer, and A. M. Iacopino. 1993. “Phenytoin Increases Gene Expression for Platelet-Derived Growth Factor B Chain in Macrophages and Monocytes.”Journal of Periodontology 64(3): 169–173. doi:10.1902/jop.1993.64.3.169.88
24. Shafik Goda El Zayat, MB, BCh, FRCS, Preliminary Experience with Topical Phenytoin in Wound Healing in a War Zone, Military Medicine, Volume 154, Issue 4, April 1989, Pages 178–180, https://doi.org/10.1093/milmed/154.4.178
25. Rhodes RS, Heyneman CA, Culbertson VL, WilsonSE, Phatak HM. Topical phenytoin treatment of stage II decubitus ulcers in the elderly. Ann Pharmacother.2001;35(6):675-681.
26. Simpson, G M et al. “Use of Sodium Diphenylhydantoin in Treatment of Leg Ulcers.” New York state journal of medicine vol. 65 (1965): 886-8.
27. Modaghegh S, Salehian B, Tavassoli M et al. Use of phenytoin in healing of war and non war wounds. A pilot study of 25 cases. Int J Dermatol 1989; 28:347–50.
28. Pendse AK, Sharma A, Sodani A, Hada S. Topical phenytoin in wound healing. Int J Dermatol 1993; 32:214–17.
29. Lodha SC, Lohiya ML, Vyas MC et al. Role of phenytoin in healing of large abscess cavities. Br J Surg 1991; 78:105–8.
30. Bansal NK, Mukul MD. Comparison of topical phenytoin with normal saline in the treatment of chronic trophic ulcers in leprosy. Int J Dermatol 1993; 32:210–13.
31. El-Nahas, M., Gawish, H., Tarshoby, M., State, O. The impact of topical phenytoin on recalcitrant neuropathic diabetic foot ulceration. J Wound Care. 2009; 18: 33–37.
32. Manoj VV, Stephen B. A study to compare the effect of topical phenytoin dressing and conventional saline dressing in chronic nonhealing ulcers. Int Surg J 2021;8:2078-84.89
33. Selvaraj, Jayaraman, and Solaiappan Jeevaraman. "Efficiency of topical phenytoin on healing in diabetic ulcer: a randomized control trial." Journal of Evolution of Medical and Dental Sciences, vol. 5, no. 23, 21 Mar. 2016, pp. 1225+. Gale OneFile: Health and Medicine.
34. Mason J, O'Keeffe C, Hutchinson A, et al. A systematic review of foot ulcer in patients with Type 2 diabetes mellitus - II: treatment. 1999. In: Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet]. York (UK): Centre for Reviews and Dissemination (UK); 1995
35. V. Patil, R. Patil, P. L. Kariholu, L. S. Patil and P. Shahapur, J. Clin. Diagn. Res., 2013, 7, 2238–2240
36. J.A. Jayalal et al. Efficiency of topical phenytoin on healing in diabetic foot ulcer: a randomized controlled trial Int J Sci Stud (Jun 2015)
37. El-Nahas M, Gawish H, Tarshoby M, State O. The impact of topical phenytoin onrecalcitrant neuropathic diabetic foot ulceration. J Wound Care 2009;18:33– 7. https://doi.org/10.12968/jowc.2009.18.1.32146.
38. DaCosta ML, Regan MC, Al Sader M, Leader M, Bouchier-Hayes D. Diphenylhydantoin sodium promotes early and marked angiogenesis and results in increased collagen deposition and tensile strength in healing wounds. Surgery. 1998;123:287–93. [PubMed] [Google Scholar]
39. Bharathi Mohan P, Chapa UK, Chittoria RK, et al. Role of Phenytoin in Diabetic Foot Ulcers. J Cutan Aesthet Surg. 2020;13(3):222-225.doi:10.4103/JCAS.JCAS_48_19
40. Firmino F, de Almeida AM, e Silva RdeJ et al. Scientific production on the applicability of phenytoin in wound healing. Rev Esc Enferm USP 2014; 48:166-73. https://doi.org/ 10.1590/S0080-623420140000100021